Discovery of Non-Carboxylic Steroidal FXR Agonist as a Promising Preclinical Candidate for Metabolic Dysfunction-Associated Steatohepatitis
Journal of Medicinal Chemistry · 28.05.2026 · 69 (10) · 11872-11899
DOI: 10.1021/acs.jmedchem.5c03220 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 08.05.2026. Verfasst von Zhe Zhang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), South China University of Technol…. Hauptthemen laut MEDLINE: Receptors, Cytoplasmic and Nuclear, Drug Discovery, Fatty Liver. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 65 Literaturangaben. Gefördert von: Zhongshan Science and Technology Bureau.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), South China University of Technology, Guangzhou 510000, China.
- Department of Clinical Laboratory Medicine, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou 510000, China.
- MOE International Joint Lab for Synthetic Biology and Medicines, School of Biology and Biological Engineering, South China University of Technology, Guangzhou 510000, China.
Förderung
- Zhongshan Science and Technology Bureau
Zitieren
APA
Zhang, Z., Zheng, X., Dong, C., Li, P., Lin, Y., Sun, Z., Li, W., Liu, X., Li, J., Li, S., Gu, B., & Zhang, L. (2026). Discovery of Non-Carboxylic Steroidal FXR Agonist as a Promising Preclinical Candidate for Metabolic Dysfunction-Associated Steatohepatitis. Journal of Medicinal Chemistry, 69(10), 11872-11899. https://doi.org/10.1021/acs.jmedchem.5c03220
Vancouver
Zhang Z, Zheng X, Dong C, Li P, Lin Y, Sun Z, et al. Discovery of Non-Carboxylic Steroidal FXR Agonist as a Promising Preclinical Candidate for Metabolic Dysfunction-Associated Steatohepatitis. Journal of Medicinal Chemistry. 2026;69(10):11872-11899. doi:10.1021/acs.jmedchem.5c03220
BibTeX
@article{Zhang2026,
author = {Zhang, Zhe and Zheng, Xiaomin and Dong, Chuyu and Li, Pengru and Lin, Yi and Sun, Zhenzhu and Li, Wenjing and Liu, Xiaoxiao and Li, Jing and Li, Shan and Gu, Bing and Zhang, Lei},
title = {Discovery of Non-Carboxylic Steroidal FXR Agonist as a Promising Preclinical Candidate for Metabolic Dysfunction-Associated Steatohepatitis},
journal = {Journal of Medicinal Chemistry},
year = {2026},
volume = {69},
number = {10},
pages = {11872--11899},
doi = {10.1021/acs.jmedchem.5c03220}
}
EUVIMED